Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2025-12-27 @ 12:10 PM
Study NCT ID:
NCT00792467
Status:
COMPLETED
Last Update Posted:
2021-05-11
First Post:
2008-11-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Trial of the Histone-Deacetylase Inhibitor ITF2357 Followed by Mechlorethamine in Relapsed/Refractory Hodgkin's Lymphoma
Sponsor:
Italfarmaco
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-02
Start Date Type:
None
Primary Completion Date:
2010-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-09
Completion Date Type:
ACTUAL
First Submit Date:
2008-11-17
First Submit QC Date:
None
Study First Post Date:
2008-11-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-03-22
Results First Submit QC Date:
None
Results First Post Date:
2021-04-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-04-20
Last Update Post Date:
2021-05-11
Last Update Post Date Type:
ACTUAL